Sirona Biochem Announces Grant of Stock Options
Sirona Biochem CEO Letter to Shareholders
Sirona Biochem Reports 100% Safety in First Tox Study for Increased Concentration of TFC-1067
Sirona Biochem Proceeds to First Clinical Tests for Higher Concentrations to Increase Commercial Value of Skin Lightening Compound TFC-1067
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 47
- Next Page »